The purpose of this paper is to share best practice and guidance for using the ‘Biomanufacturing digitalization readiness model’ (BDRM) published in Part 1: BioPhorum Digital Technology Roadmap (DTR)1. Visualizing the characteristics of a successful digital transformation, the BDRM is used to assess the organizational status of important attributes and identify gaps in need of attention.
Digital Technology Roadmap
Viewing related articles
This position paper and supporting personas from the BioPhorum Technology Adoption team address the issue of where to start our industry’s digital transformation journey. Part of the answer is data governance and the pressing need to collaborate and agree on a standard set of taxonomies and ontologies for the biopharmaceutical industry, recognizing that these standards will need sufficient flexibility to allow innovation. As a first step, we propose that the industry adopt The FAIR Guiding Principles for scientific data management and stewardship.
This BioPhorum member only document contains some of the typical biomanufacturing personas discussed in the BioPhorum Data Governance team.
This paper outlines the foundational element that chart the course for pharmaceutical manufacturers who decide to take this journey and provides a vision of what that destination could look like in 10 years’ time. It outlines the current state of the industry, key challenges and barriers to adoption, and hints at the value that taking this journey will bring to patients, organizations and industry. This paper (which forms Part 1 of the Digital Technology Roadmap) looks at the problem statement and the work that has gone before.